Doubles Production Capacity in 7- Hour Cycle, Enabling Efficient, Global Scale Potential

Rise Nano Optics Inc. (“Rise” or the “Company”), a health-technology innovator specializing in nano-optic solutions to prevent vision stress and eye disease, is pleased to announce a significant breakthrough in its proprietary research and development program, achieving transformative improvements in production efficiency and scalability.

Production Efficiency Highlights

• 100% increase in lens units produced per 7-hour cycle
• Production capacity expanded to support tens of thousands of high-precision lenses per setup
• Rapid replication model, enabling deployment of scalable production across multiple labs and facilities

These advancements are powered by a newly developed nanomaterials complex and Rise’s proprietary diffusion process. By leveraging higher reactant concentrations, the Company can now produce more complex particles at consistent quality, directly enhancing manufacturing throughput and scalability.

“Our breakthrough represents a step-change in how nano-optic lenses can be manufactured at scale,” said Inas Said, Founder and CEO of Rise Nano Optics. “Doubling our production capacity provides us with the foundation to meet surging global demand for preventative vision care while ensuring our technology is accessible to millions.”

Strategic Outlook

The enhanced production model is designed for swift replication, providing a clear pathway to accelerate market entry in the US$160 billion global eyewear market, including the US$1.6 billion diabetic lens segment.

Rise continues to advance toward final product approval and registration, anticipated by the end of September 2025, supporting the Company’s Q3 2025 North American launch strategy.

As previously announced, Rise is progressing its regulatory strategy and anticipates securing final product approval and registration by the end of September 2025. This milestone will pave the way for the launch of its North American market penetration strategy in Q3 2025. In parallel, Rise is advancing its capital markets initiatives, with plans to list on the Canadian Securities Exchange (“CSE”) under the ticker symbol “EYE,” followed by expansion into international markets.

About Rise Health Nano Optics Inc.

Rise is a health technology company specializing in nano-optic solutions that address preventable vision stress and eye disease. Its patented EYEGUARD™ technology is at the intersection of innovation, preventative care, and consumer health — targeting the global eyewear market, with strong relevance to diabetes-related vision impairments and the rapidly growing wellness wearables space.

To learn more, visit: www.risenanooptics.com

Investor Contacts: ir@risenanooptics.com

Cautionary Statements

This press release contains “forward-looking statements or information”. Forward-looking statements can be identified by words such as: anticipate, intend, plan, goal, seek, believe, project, estimate, expect, strategy, future, likely, may, should, will and similar references to future periods. Examples of forward-looking statements in this press release include statements made regarding information about future plans, expectations and objectives of the Company overall.

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. The Company may not actually achieve its plans, projections, or expectations. The forward-looking statements and information are based on certain key expectations and assumptions made by the Company. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: the adequacy of our cash flow and earnings, the availability of future financing and/or credit, developments and changes in laws and regulations, consumer sentiment towards the Company’s products, failure of counterparties to perform their contractual obligations, government regulations, competition, loss of key employees and consultants, and general economic, market or business conditions, the impact of technology and social changes on the products and industry.

Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. Except as required by applicable securities laws, we undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.